Amgen Stock Dips Ahead of Earnings Report

Amgen stock is currently trading at $378.89 after falling 1.64% on the day. The decline comes as the company prepares to release its second-quarter 2026 financial results tomorrow.

The announcement of the earnings report has not provided any new information, but traders are focusing on technical dynamics instead. According to Traders Union, shares are testing key support at $378.22, a level that could be crucial for determining the direction of the stock.

Despite the recent price action being contained within a narrow range, analysts believe there is an 80% probability of an upside move in the coming trading week. However, if the price were to drop below $378.22, it would indicate that the recent advance is facing near-term resistance.